1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)
| Autor: | Reck, M., Mileham, K.F., Clump, D.A., Decoster, L., Estival, A., Felip, E., Fried, P., Paz-Ares, L., Sebastian, M., Segarra, N. Vinolas, Surmont, V., Wagner, A., Galdy, S.M., Smit, E.F. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S897-S898 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|